TNBC: Potential Targeting of Multiple Receptors for a Therapeutic Breakthrough, Nanomedicine, and Immunotherapy

Triple-negative breast cancer (TNBC) is a heterogeneous, recurring cancer associated with a high rate of metastasis, poor prognosis, and lack of therapeutic targets. Although target-based therapeutic options are approved for other cancers, only limited therapeutic options are available for TNBC. Cel...

全面介紹

書目詳細資料

Principais autores:	Desh Deepak Singh, Dharmendra Kumar Yadav
格式:	Artigo
語言:	Inglês
出版:	MDPI AG 2021-07-01
叢編:	Biomedicines
主題:	triple-negative breast cancer therapeutic target signaling pathway clinical trial
在線閱讀:	https://www.mdpi.com/2227-9059/9/8/876
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!